Amgen Can't Enforce Biosimilar Law, Hospira Says
Amgen Inc. can't enforce a federal law that calls for biosimilar makers to share manufacturing information and provide advance notice of sales, Hospira Inc. told a Delaware federal judge on Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article